Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH, Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P. Kaufman HL, et al. Among authors: brownell i. Lancet Oncol. 2016 Oct;17(10):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. Epub 2016 Sep 1. Lancet Oncol. 2016. PMID: 27592805 Free PMC article. Clinical Trial.
Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma.
Lok B, Khan S, Mutter R, Liu J, Fields R, Pulitzer M, Shi W, Zhang Z, Kraus D, Pfister D, Busam KJ, Brownell I, Lee N. Lok B, et al. Among authors: brownell i. Cancer. 2012 Aug 15;118(16):3937-44. doi: 10.1002/cncr.26738. Epub 2011 Dec 16. Cancer. 2012. PMID: 22180314 Free PMC article.
Merkel Cell Carcinoma Therapeutic Update.
Cassler NM, Merrill D, Bichakjian CK, Brownell I. Cassler NM, et al. Among authors: brownell i. Curr Treat Options Oncol. 2016 Jul;17(7):36. doi: 10.1007/s11864-016-0409-1. Curr Treat Options Oncol. 2016. PMID: 27262710 Free PMC article. Review.
Hedgehog Signaling Inhibitors Fail to Reduce Merkel Cell Carcinoma Viability.
Carroll TM, Williams JS, Daily K, Rogers T, Gelb T, Coxon A, Wang SQ, Crago AM, Busam KJ, Brownell I. Carroll TM, et al. Among authors: brownell i. J Invest Dermatol. 2017 May;137(5):1187-1190. doi: 10.1016/j.jid.2017.01.008. Epub 2017 Jan 25. J Invest Dermatol. 2017. PMID: 28130073 Free PMC article. No abstract available.
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Milella M, Brownell I, Lewis KD, Lorch JH, von Heydebreck A, Hennessy M, Nghiem P. Kaufman HL, et al. Among authors: brownell i. J Immunother Cancer. 2018 Jan 19;6(1):7. doi: 10.1186/s40425-017-0310-x. J Immunother Cancer. 2018. PMID: 29347993 Free PMC article. Clinical Trial.
PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.
Gaiser MR, Bongiorno M, Brownell I. Gaiser MR, et al. Among authors: brownell i. Expert Rev Clin Pharmacol. 2018 Apr;11(4):345-359. doi: 10.1080/17512433.2018.1445966. Epub 2018 Mar 14. Expert Rev Clin Pharmacol. 2018. PMID: 29478343 Free PMC article. Review.
101 results